MarketInOut Stock Screener Log In | Sign Up
 

Sutro Biopharma Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 06/25/2026 14:29
Sutro Biopharma Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization483.69 mln
Float10.30 mln
Earnings Date08/10/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-0.94
Highly suspicious

1-Year Forecast

48.31
Transformational upside

Relative Strength

92 / 100
Top performer

Debt / Equity

-0.20
Negative equity

Dividend Yield

0.00%
No dividend

Business Description

Sutro Biopharma is a California-based biotechnology company focused on developing advanced cancer treatments and vaccines. Its core work centers on a proprietary cell-free protein synthesis technology used to create a new generation of antibody-drug conjugates, which are precision medicines designed to target and destroy cancer cells while minimizing harm to healthy tissue. The company's cancer pipeline targets a range of solid tumors and blood cancers, while its vaccine programs address serious infectious diseases such as pneumococcal illness. Sutro works alongside several major pharmaceutical partners, including Ipsen, Astellas, and Vaxcyte, to bring these therapies to patients around the world.

Key Fundamentals

EPS-16.35
RPS11.12
ROIC-110
ROA-63.51
EBITDA, mln-105
EV / EBITDA-2.75
EV / EBIT-2.59
Revenue, mln99.61
EV / Revenue2.90

Financial Strength

Altman Z-Score-5.32
Piotroski F-Score 5 / 9
Beneish M-Score-0.94
1-Year Target Price48.31
Short Ratio2.35
Short % of Float4.55

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 6.05% 88 / 100   
1 Month 10.04% 87 / 100   
2 Months 38.27% 89 / 100   
6 Months 191% 98 / 100   
1 Year 267% 97 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us